跳至主要内容
临床试验/CTRI/2025/07/091245
CTRI/2025/07/091245尚未招募4 期

ASSESSMENT OF THE THERAPEUTIC EFFICACY OF TERBINAFINE AND GRISEOFULVIN IN CHILDREN WITH TINEA CAPITIS ALONG WITH CLINICOMYCOLOGICAL CORRELATION

Not applicable1 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2025年7月30日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
77
试验地点
1
主要终点
Assessment of therapeutic efficacy of Terbinafine and Griseofulvin

研究概览

简要总结

This study is a randomised controlled trial comparing the therapeutic efficacy of oral Terbinafine and oral Griseofulvin in children(2-18 years) with tinea capitis and clinicomycological correlation at a single centre(Madras medical college). The primary outcome will be the assessment of therapeutic efficacy of terbinafine and griseofulvin.The secondary outcome will be the identification of  species causing tinea capitis in children(2-18 years)

研究设计

研究类型
Interventional
分配方式
Randomized

入排标准

年龄范围
2.00 Year(s) 至 18.00 Year(s)(—)
性别
All

入选标准

  • Potassium hydroxide(KOH) wet mount positive cases of tinea capitis, Age group : greater than or equal to 2 years and lesser than or equal to 18 years of age, Patients who are willing to be enrolled in the study.

排除标准

  • Patients who have taken any oral or topical antifungal therapy within four weeks prior to inclusion in the study, Hepatic disease, Renal disease, Allergy to Griseofulvin and Terbinafine.

结局指标

主要结局

Assessment of therapeutic efficacy of Terbinafine and Griseofulvin

时间窗: 1 year

次要结局

  • Identification of species causing Tinea capitis(1 year)

研究者

发起方
Not applicable
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Mohamed akram N

Madras medical college

研究点 (1)

Loading locations...

相似试验